Home/Pipeline/PEPR401

PEPR401

Inflammation

In-vivoPreclinical

Key Facts

Indication
Inflammation
Phase
In-vivo
Status
Preclinical
Company

About Peptris Technologies Private

AI-driven drug discovery company using proprietary generative AI to design novel molecules and repurpose drugs for oncology, inflammation, and rare diseases.

View full company profile

Other Inflammation Drugs